Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice (NorTick_EM)

This study has been completed.
Sponsor:
Collaborators:
Norwegian Institute of Public Health
Sorlandet Hospital HF
Norwegian University of Life Sciences
Information provided by (Responsible Party):
Morten Lindbaek, University of Oslo
ClinicalTrials.gov Identifier:
NCT01368341
First received: June 6, 2011
Last updated: December 11, 2014
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2014
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)